购物车
- 全部删除
- 您的购物车当前为空
Rosiptor (AQX-1125) 是一种选择性,具有口服活性的磷酸酶 SHIP1激活剂。它在体外抑制 Akt 磷酸化、炎症介质生成和白细胞趋化,具有抗炎作用。
Rosiptor (AQX-1125) 是一种选择性,具有口服活性的磷酸酶 SHIP1激活剂。它在体外抑制 Akt 磷酸化、炎症介质生成和白细胞趋化,具有抗炎作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,160 | 期货 | |
5 mg | ¥ 2,890 | 期货 | |
10 mg | ¥ 3,970 | 期货 | |
25 mg | ¥ 6,520 | 期货 | |
50 mg | ¥ 9,130 | 期货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,180 | 期货 |
产品描述 | Rosiptor (AQX-1125) (AQX-1125) is an orally-active and specific phosphatase SHIP1 activator with anti-inflammatory effects. |
体外活性 | In MOLT-4 but not Jurkat cells, Rosiptor (0.1-10 μM, 30 minutes) inhibits Akt activation [1]. |
体内活性 | Rosiptor (10 mg/kg, p.o.) has the Cmax value of 0.830 μM and the t1/2 value of 5.2 hours. AQX-1125 also exhibits >80% oral bioavailability [1]. Rosiptor (3-30 mg/kg, p.o., daily for 3 days) significantly reduces the total number of BAL leukocytes in NSC-125066-challenged mice and reduces MPO activity [2]. |
细胞实验 | Cell Line: MOLT-4 cells and SHIP1-deficient Jurkat cells (IGF-1 stimulation) [1]. Concentration: 0.1, 1, 10 μM. Incubation Time: 30 minutes |
动物实验 | Animal Model: 6-8 weeks old male CD-1 mice[1]. Dosage: 3, 10, 30 mg/kg. Administration: p.o., daily for 3 days |
别名 | AQX-1125, 洛司普托 |
分子量 | 321.5 |
分子式 | C20H35NO2 |
CAS No. | 782487-28-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 145 mg/mL (451 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.